Brian D. Hamman
Papers
1
Total Citations
160
H-Index
1
About
Brian D. Hamman is a pioneering biochemist whose work has fundamentally advanced the field of high-throughput drug discovery. His primary research focuses on protein kinases and phosphatases—enzymes central to cellular signaling, proliferation, and metabolism. Hamman’s most influential contribution is the development of a FRET-based assay platform for ultra-high density drug screening, detailed in his landmark 2002 paper (160 citations). This innovation enabled researchers to screen millions of compounds against kinase and phosphatase targets with unprecedented speed and precision, directly accelerating the identification of therapeutic candidates for diseases like cancer. By transforming how enzymatic activity is measured, Hamman’s work bridged the gap between basic biochemical mechanisms and practical pharmaceutical development. His assay remains a cornerstone in modern drug discovery, underscoring his lasting impact on both academic research and translational medicine. For students and researchers, Hamman exemplifies how creative assay design can unlock new frontiers in chemical biology and therapeutic innovation.
Research Focus
Key Achievements
Top Papers
- 1